Entrepreneurs-in-Residence (EIR)

NUCATS works with two EIRs at the Innovation and New Venture Office (INVO) that are dedicated to the biomedical space. Please contact Nick Maull for connections to EIRs. 

Andrew Mazar

EIR for therapeutics and Director of the Center for Developmental Therapeutics. He has extensive experience in drug development, having been involved in several biotech companies that have taken drugs from the bench all the way into Phase II clinical trials. He can provide advice on how to move a potential therapeutic down the path from target to prep for clinical trials, including suggestions on funding sources and vetted service providers.

Dan Schmitt

Dan has extensive experience in drug development from Searle, Fujisawa, Ilex, Genus, etc. Dan works closely with faculty at the Feinberg School of Medicine and the Center for Developmental Therapeutics to speed translation of potential new therapeutics and diagnostics and improve efficiency by developing, monitoring, and updating timelines and milestones required to move innovations from the lab bench to the clinic.